Skip to main content

Table 2 Correlations between EQ-5D-3L and Other Outcome Measures Using Multiple Imputation

From: Convergent validity of the EQ-5D-3L in a randomized-controlled trial of the Housing First model

Stratum and Time QOLI-20 CSI RAS Comorbidities
All
 0 0.52 (0.47 to 0.58) −0.57a (− 0.63 to − 0.51) 0.42a (0.36 to 0.47) − 0.51a (− 0.57 to − 0.44)
 6 0.43 (0.37 to 0.48) − 0.53a (− 0.58 to − 0.48)
 12 0.47 (0.41 to 0.53) − 0.54a (− 0.59 to − 0.48)
 18 0.40 (0.33 to 0.45) − 0.47a (− 0.54 to − 0.42)
 24 0.37 (0.31 to 0.43) − 0.47a (− 0.52 to − 0.41) 0.31a (0.24 to 0.38)
High Needs Mental Illness
 0 0.49 (0.38 to 0.58) − 0.63a (− 0.71 to − 0.52) 0.43a (0.34 to 0.52) − 0.59a (− 0.68 to − 0.49)
 6 0.40 (0.32 to 0.49) − 0.51a (− 0.60 to − 0.43)
 12 0.46 (0.39 to 0.52) − 0.52a (− 0.58 to − 0.43)
 18 0.42 (0.31 to 0.52) − 0.51a (− 0.59 to − 0.42)
 24 0.39 (0.28 to 0.48) − 0.50a (− 0.58 to − 0.40) 0.34a (0.22 to 0.44)
Moderate Needs Mental Illness
 0 0.54 (0.46 to 0.59) − 0.53a (− 0.58 to − 0.45) 0.40a (0.33 to 0.49) −0.44a (− 0.54 to − 0.36)
 6 0.44 (0.38 to 0.52) −0.55a (− 0.62 to − 0.48)
 12 0.48 (0.40 to 0.55) −0.55a (− 0.62 to − 0.48)
 18 0.38 (0.30 to 0.46) −0.45a (− 0.53 to − 0.37)
 24 0.35 (0.27 to 0.43) −0.45a (− 0.51 to − 0.37) 0.30 (0.21 to 0.37)
High Thought Impairment
 0 0.52 (0.42 to 0.61) −0.62a (− 0.71 to − 0.53) 0.40a (0.30 to 0.49) −0.56a (− 0.65 to − 0.47)
 6 0.35 (0.21 to 0.45) −0.55a (− 0.64 to − 0.44)
 12 0.44 (0.32 to 0.54) −0.59a (− 0.67 to − 0.49)
 18 0.41 (0.22 to 0.53) −0.48a (− 0.62 to − 0.27)
 24 0.41 (0.27 to 0.55) −0.45a (− 0.59 to − 0.24) 0.24 (− 0.02 to 0.41)
Low Thought Impairment
 0 0.52 (0.44 to 0.58) − 0.52a (− 0.59 to − 0.45) 0.43a (0.35 to 0.51) −0.45a (− 0.55 to − 0.35)
 6 0.47 (0.37 to 0.54) −0.54a (− 0.62 to − 0.47)
 12 0.49 (0.40 to 0.57) −0.52a (− 0.60 to − 0.42)
 18 0.38 (0.28 to 0.48) −0.46a (− 0.54 to − 0.37)
 24 0.33 (0.23 to 0.43) −0.45a (− 0.52 to − 0.37) 0.33a (0.24 to 0.42)
High Interview Confidence Only
 0 0.54 (0.45 to 0.61) −0.48a (− 0.57 to − 0.33) 0.39a (0.28 to 0.51) −0.45a (− 0.56 to − 0.33)
 6 0.49 (0.39 to 0.57) −0.53a (− 0.61 to − 0.41)
 12 0.51 (0.38 to 0.61) −0.46a (− 0.58 to − 0.36)
 18 0.38 (0.25 to 0.49) −0.48a (− 0.58 to − 0.35)
 24 0.42 (0.30 to 0.52) −0.53a (− 0.62 to − 0.41) 0.37a (0.24 to 0.46)
High or Moderate Interviewer Confidence Only
 0 0.52 (0.46 to 0.57) −0.56a (− 0.62 to − 0.51) 0.42a (0.35 to 0.48) −0.49a (− 0.56 to − 0.42)
 6 0.40 (0.34 to 0.47) −0.52a (− 0.57 to − 0.45)
 12 0.47 (0.40 to 0.55) −0.52a (− 0.59 to − 0.45)
 18 0.38 (0.31 to 0.46) −0.45a (− 0.52 to − 0.37)
 24 0.35 (0.27 to 0.44) −0.45a (− 0.52 to − 0.38) 0.34a (0.28 to 0.42)
  1. QOLI-20 Lehman Quality of Life Interview 20 index total, CSI Colorado Symptom Index, RAS Recovery Assessment Scale
  2. a Met pre-defined threshold for correlation (r > |0.6| for QOLI-20, r > |0.3| for CSI, RAS, and number of comorbidities)